Mefloquine blockade of pannexin1 currents: Resolution of a conflict

Rodolfo Iglesias, David C. Spray, Eliana Scemes

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The authors' laboratory has reported potent block of Pannexin1 (Panx1) currents by the antimalarial quinine derivative mefloquine. However, other laboratories have found little or no mefloquine sensitivity of Panx1 currents or processes attributable to these channels. In order to resolve this issue, the authors have performed extensive dose-response studies on Panx1-transfected neuroblastoma (Neuro2A) and rat insulinoma (Rin) cells, comparing mefloquine obtained from three suppliers and also comparing the sensitivity to diastereomers. Results indicate a 20-fold difference in sensitivity to the (-)-threo-(11R/2R) diastereomer compared to the erythro enatiomers and much lower potency of (±)-erythro-(Rz.ast;/Sz.ast;)-mefloquine obtained from one of the commercial sources. This markedly lower efficacy presumably accounts for the disparity in results from different laboratories who have applied it in Panx1 studies.

Original languageEnglish (US)
Pages (from-to)131-137
Number of pages7
JournalCell Communication and Adhesion
Volume16
Issue number5-6
DOIs
StatePublished - 2010

Fingerprint

Mefloquine
Negotiating
Insulinoma
Quinine
Antimalarials
Neuroblastoma
Rats
Derivatives

Keywords

  • Hemichannel
  • Isomers
  • Lariam
  • Mefloquine
  • Pannexin
  • Voltage clamp

ASJC Scopus subject areas

  • Cell Biology
  • Clinical Biochemistry

Cite this

Mefloquine blockade of pannexin1 currents : Resolution of a conflict. / Iglesias, Rodolfo; Spray, David C.; Scemes, Eliana.

In: Cell Communication and Adhesion, Vol. 16, No. 5-6, 2010, p. 131-137.

Research output: Contribution to journalArticle

Iglesias, Rodolfo ; Spray, David C. ; Scemes, Eliana. / Mefloquine blockade of pannexin1 currents : Resolution of a conflict. In: Cell Communication and Adhesion. 2010 ; Vol. 16, No. 5-6. pp. 131-137.
@article{316c743c1be64615bc19ff4503eb11ca,
title = "Mefloquine blockade of pannexin1 currents: Resolution of a conflict",
abstract = "The authors' laboratory has reported potent block of Pannexin1 (Panx1) currents by the antimalarial quinine derivative mefloquine. However, other laboratories have found little or no mefloquine sensitivity of Panx1 currents or processes attributable to these channels. In order to resolve this issue, the authors have performed extensive dose-response studies on Panx1-transfected neuroblastoma (Neuro2A) and rat insulinoma (Rin) cells, comparing mefloquine obtained from three suppliers and also comparing the sensitivity to diastereomers. Results indicate a 20-fold difference in sensitivity to the (-)-threo-(11R/2R) diastereomer compared to the erythro enatiomers and much lower potency of (±)-erythro-(Rz.ast;/Sz.ast;)-mefloquine obtained from one of the commercial sources. This markedly lower efficacy presumably accounts for the disparity in results from different laboratories who have applied it in Panx1 studies.",
keywords = "Hemichannel, Isomers, Lariam, Mefloquine, Pannexin, Voltage clamp",
author = "Rodolfo Iglesias and Spray, {David C.} and Eliana Scemes",
year = "2010",
doi = "10.3109/15419061003642618",
language = "English (US)",
volume = "16",
pages = "131--137",
journal = "Cell Communication and Adhesion",
issn = "1541-9061",
publisher = "Informa Healthcare",
number = "5-6",

}

TY - JOUR

T1 - Mefloquine blockade of pannexin1 currents

T2 - Resolution of a conflict

AU - Iglesias, Rodolfo

AU - Spray, David C.

AU - Scemes, Eliana

PY - 2010

Y1 - 2010

N2 - The authors' laboratory has reported potent block of Pannexin1 (Panx1) currents by the antimalarial quinine derivative mefloquine. However, other laboratories have found little or no mefloquine sensitivity of Panx1 currents or processes attributable to these channels. In order to resolve this issue, the authors have performed extensive dose-response studies on Panx1-transfected neuroblastoma (Neuro2A) and rat insulinoma (Rin) cells, comparing mefloquine obtained from three suppliers and also comparing the sensitivity to diastereomers. Results indicate a 20-fold difference in sensitivity to the (-)-threo-(11R/2R) diastereomer compared to the erythro enatiomers and much lower potency of (±)-erythro-(Rz.ast;/Sz.ast;)-mefloquine obtained from one of the commercial sources. This markedly lower efficacy presumably accounts for the disparity in results from different laboratories who have applied it in Panx1 studies.

AB - The authors' laboratory has reported potent block of Pannexin1 (Panx1) currents by the antimalarial quinine derivative mefloquine. However, other laboratories have found little or no mefloquine sensitivity of Panx1 currents or processes attributable to these channels. In order to resolve this issue, the authors have performed extensive dose-response studies on Panx1-transfected neuroblastoma (Neuro2A) and rat insulinoma (Rin) cells, comparing mefloquine obtained from three suppliers and also comparing the sensitivity to diastereomers. Results indicate a 20-fold difference in sensitivity to the (-)-threo-(11R/2R) diastereomer compared to the erythro enatiomers and much lower potency of (±)-erythro-(Rz.ast;/Sz.ast;)-mefloquine obtained from one of the commercial sources. This markedly lower efficacy presumably accounts for the disparity in results from different laboratories who have applied it in Panx1 studies.

KW - Hemichannel

KW - Isomers

KW - Lariam

KW - Mefloquine

KW - Pannexin

KW - Voltage clamp

UR - http://www.scopus.com/inward/record.url?scp=77951101287&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951101287&partnerID=8YFLogxK

U2 - 10.3109/15419061003642618

DO - 10.3109/15419061003642618

M3 - Article

C2 - 20218915

AN - SCOPUS:77951101287

VL - 16

SP - 131

EP - 137

JO - Cell Communication and Adhesion

JF - Cell Communication and Adhesion

SN - 1541-9061

IS - 5-6

ER -